A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients

To date, (p.Glu340del) mutation represents the first founder mutation identified in PGM3 gene. These findings will facilitate the development of preventive approaches through genetic counselling and prenatal diagnosis in the affected families.